Tedjarati, Sean

Synergistic therapy of human ovarian carcinoma implanted orthotopically in nude mice by optimal biological dose of pegylated interferon alpha combined with paclitaxel. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Jul 2002 - 2413-22 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

1078-0432


Animals
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Apoptosis--drug effects
Blotting, Northern
Cell Division--drug effects
Drug Synergism
Endothelial Growth Factors--metabolism
Female
Fibroblast Growth Factor 2--metabolism
Fluorescent Antibody Technique
Humans
Immunoenzyme Techniques
In Situ Nick-End Labeling
Intercellular Signaling Peptides and Proteins--metabolism
Interferon alpha-2
Interferon-alpha--administration & dosage
Interleukin-8--metabolism
Lymphokines--metabolism
Matrix Metalloproteinase 9--metabolism
Mice
Mice, Nude
Neoplasm Transplantation
Ovarian Neoplasms--drug therapy
Paclitaxel--administration & dosage
Platelet Endothelial Cell Adhesion Molecule-1--metabolism
Polyethylene Glycols
Proliferating Cell Nuclear Antigen--metabolism
Recombinant Proteins
Tumor Cells, Cultured
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors